Search
for
Sort by
Research 61–90 of 518
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report